The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Portable Ventilator Could Increase Physical Activity in Respiratory Conditions
October 26th 2015It's already well-known that greater activity translates to lower levels of mortality when it comes to chronic respiratory conditions. The latest data indicates that the Non-invasive Open Ventilation (NIOV) device be able to increase physical activity.
Identifying Patients Before They Need the ICU
October 25th 2015"A lot of us know that, essentially, if you don't rescue the patient from falling off a cliff, there's a negative patient outcome," Nathan Boyer, CPT (P), MC, from the Brooke Army Medical Center in Texas, began a presentation at the CHEST 2015 meeting in Montréal, Canada.
Twitter Talk Surpasses Pulmonary Conference Attendees
October 25th 2015Millennials aren't the only ones using social media; professionals and the minds behind credible institutions have taken to the websites to spread their news and messages. A recent analysis that will be described at CHEST 2015 in Montréal, Canada found just how prominent Twitter discussions are at pulmonary conferences – including CHEST over the years.
Less Than a Quarter of Pulmonary Clinical Trials Report Ethnicity
October 25th 2015When the Food and Drug Administration Amendment Act (FDAAA) went into effect in 2007, summaries from clinical trials were required to be posted to ClinicalTrials.gov. While demographics are required in data, race/ethnicity are not, and an alarming amount of pulmonary studies did not report the optional information.
COPD: Yoga Just as Effective as Standard Pulmonary Rehabilitation
October 25th 2015Imagine if there was a wallet-friendly rehabilitation strategy for patients with chronic obstructive pulmonary disease (COPD) that provides the same benefits as standard care. Well, you can stop imagining and see it for yourself.
Pre-Lung Transplant Symptoms Commonly Include Psychiatric Conditions
October 25th 2015It's not unheard of for patients waiting to get lung transplants to suffer from psychiatric symptoms. In fact, it's actually common and the symptoms aren't limited to those who previously had psychiatric conditions.
Researchers to Study Biomarkers for Early Detection of Diabetic Kidney Disease
October 24th 2015As part of a multi-institutional effort, researchers in the fields of proteomics, lipidomics, and metabolomics will collaborate to discover more effective ways of predicting which patients with type 1 diabetes are at greater risk for developing kidney disease.
Lipids: Local Anesthetic Systemic Toxicity and Broader Applications
October 22nd 2015Lipid resuscitation therapy was identified in 1998 as an effective treatment for local anesthetic systemic toxicity. Since then, researchers have developed a better understanding of the risk factors involved and the manner in which lipids work, using both dynamic scavenging and direct cardiotonic effects.
FMT Passes First Randomized Placebo-Controlled Trial for Treating C. Diff Infection
Fecal micriobiota transplant has been moving into mainstream medicine even without any randomonized placebo controlled trials showing it works for treating recurrent C. difficile infection. Now a long-awaited trial confirms that it works.
Using Non-Insulin Drug Therapies in Type 1 Diabetes: Promising Future
October 21st 2015Type 1 diabetes mellitus (T1DM) is treated by necessity with insulin analogues in an attempt to mimic normal physiological insulin profiles. Regardless, this approach is rarely completely successful and most T1DM patients experience fluctuating or suboptimal glucose control, significant hypoglycemia and microvascular tissue complications.
Restoring the Ability to Say No: Programming Food Responses
October 21st 2015Most adults in developed nations struggle with their weight. Ample quantities of high-quality foods (and plenty of sugar- and fat-laden snacks) do more than just nourish us. They allow us to overindulge; in fact, they tend to make people eat mindlessly.
IBS Is Yielding as Drugs, Treatments Proliferate
Treatments for irritable bowel system are proliferating. In addition to new drugs, more drug candidates are entering the approval pipeline. Even as physicians await these new products, their patients are getting into the act by doing internet research and other reading-and tv watching-that has them trying unproven remedies with mixed results.